✦ LIBER ✦
PCN70 Cost Effectiveness Analysis Based on Progression Free Survival (PFS) of Pazopanib Versus Sunitinib for the Treatment of Advanced Renal Cell Carcinoma (ARCC) in the Mexican Context
✍ Scribed by Anaya, P.; Delea, T.E.; Pichardo, P.; Diaz, J.R.
- Book ID
- 122300835
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 61 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.